UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051990
Receipt number R000059329
Scientific Title The effects of peptide on mood states : A randomized, double-blind, placebo-controlled study
Date of disclosure of the study information 2023/08/24
Last modified on 2024/09/03 09:28:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of peptide on mood states : A randomized, double-blind, placebo-controlled study

Acronym

The effects of peptide on mood states : A randomized, double-blind, placebo-controlled study

Scientific Title

The effects of peptide on mood states : A randomized, double-blind, placebo-controlled study

Scientific Title:Acronym

The effects of peptide on mood states : A randomized, double-blind, placebo-controlled study

Region

Japan


Condition

Condition

None

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of peptide intake on mood states.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

POMS2 Japanese Adult Short version

Key secondary outcomes

1. Hospital Anxiety and Depression Scale
2. Chalder Fatigue Scale
3. Subjective fatigue (Visual Analog Scale)
4. OSA sleep inventory MA version


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of sachet containing peptide for 8 weeks

Interventions/Control_2

Intake of placebo sachet for 4 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Subjects between 18 to 64 years old

Key exclusion criteria

1) Subjects who use supplements, functional foods, or drugs associated with mental health.
2) Subjects with a history of and/or current mental illness or suspicion of mental illness.
3) Subjects who are undergoing medical treatment or have a previous medical history of serious diseases.
4) Subjects who have excessive alcoholic drinks (more than 60 g/day of alcohol).
5) Subjects who have severe drug allergy or severe food allergy, and/or a previous medical history of such allergies.
6) Subjects who participated in other clinical studies within 1 month before giving informed consent to participate in this study, or are planning to participate in other studies during this study.
7) Subjects who are pregnant or lactating, or who are expected to be pregnant during the study.
8) Subjects who are judged as ineligible to participate in this study by the principal investigator based on their background, physical findings, and so on.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Ishihara
Middle name
Last name Shunichi

Organization

Faculty of Human Sciences

Division name

Faculty of Human Sciences

Zip code

343-8511

Address

3337 Minami-Ogishima, Koshigaya-shi, Saitama, JAPAN

TEL

048-974-8811

Email

ishifara@bunkyo.ac.jp


Public contact

Name of contact person

1st name Tsuzuki
Middle name
Last name Keisuke

Organization

Bunkyo University

Division name

Faculty of Health and Nutrition

Zip code

253-8550

Address

1100 Namegaya, Chigasaki-shi, Kanagawa, JAPAN

TEL

0467-53-2111

Homepage URL


Email

tsuzuki@bunkyo.ac.jp


Sponsor or person

Institute

Bunkyo University

Institute

Department

Personal name



Funding Source

Organization

Morinaga Milk Industry Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Bunkyo University Faculty of Health and Nutrition.

Address

1100 Namegaya, Chigasaki-shi, Kanagawa, JAPAN

Tel

0467-53-2111

Email

matumura@bunkyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 07 Month 25 Day

Date of IRB

2023 Year 07 Month 25 Day

Anticipated trial start date

2023 Year 08 Month 24 Day

Last follow-up date

2023 Year 11 Month 28 Day

Date of closure to data entry

2023 Year 12 Month 20 Day

Date trial data considered complete

2024 Year 02 Month 26 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 08 Month 24 Day

Last modified on

2024 Year 09 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059329